Diment S, Leech M S, Stahl P D
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110.
J Biol Chem. 1988 May 15;263(14):6901-7.
Previously we identified an acid protease activity which was located in the endosomes of rabbit alveolar macrophages (Diment, S., and Stahl, P.D. (1985) J. Biol. Chem. 260, 15311-15317). In this study, the endosomal protease is identified as cathepsin D by immunoprecipitation with polyclonal antibodies raised against rabbit cathepsin D and by NH2-terminal sequence. In order to elucidate the mechanism for targeting of cathepsin D to endosomes, we first examined the membrane association of cathepsin D with light (rho = 1.05 g/ml) and heavy density (rho = 1.1 g/ml) vesicles from Percoll density gradients. After sequential washes, 8.4 and 21.9% of cathepsin D activity remained associated with heavy and light density vesicles, respectively. This membrane-associated cathepsin D could not be solubilized in either buffer at pH 5.0 containing mannose 6-phosphate and EDTA or in buffer at pH 10.6. Solubilization required the detergent Triton X-100. To determine whether membrane-associated cathepsin D was found in endosomes, the enzyme was radioiodinated within endosomes and lysosomes with internalized lactoperoxidase. The membrane-associated form was detected in endosomes, but much less in lysosomes. Biosynthetic studies combined with the same extraction procedure revealed that macrophage cathepsin D is first synthesized as an inactive membrane-associated precursor. The precursor is processed to an active, membrane-associated form and then to the active soluble form found in lysosomes. Our studies provide evidence that 1) cathepsin D is in endosomes of macrophages; 2) cathepsin D is transported to endosomes as a membrane-associated form; and 3) the membrane-associated form is a biosynthetic precursor for the soluble form found in endosomes and lysosomes.
此前我们鉴定出一种酸性蛋白酶活性,其位于兔肺泡巨噬细胞的内体中(迪门特,S.,和斯塔尔,P.D.(1985年)《生物化学杂志》260,15311 - 15317)。在本研究中,通过用针对兔组织蛋白酶D产生的多克隆抗体进行免疫沉淀以及通过氨基末端序列,将内体蛋白酶鉴定为组织蛋白酶D。为了阐明组织蛋白酶D靶向内体的机制,我们首先检查了组织蛋白酶D与来自Percoll密度梯度的轻(ρ = 1.05 g/ml)和重密度(ρ = 1.1 g/ml)囊泡的膜结合情况。经过连续洗涤后,分别有8.4%和21.9%的组织蛋白酶D活性与重密度和轻密度囊泡相关。这种与膜结合的组织蛋白酶D在含有甘露糖6 - 磷酸和EDTA的pH 5.0缓冲液或pH 10.6缓冲液中均不能溶解。溶解需要去污剂Triton X - 100。为了确定在内体中是否发现了与膜结合的组织蛋白酶D,用内化的乳过氧化物酶在含有内体和溶酶体的体系中对该酶进行放射性碘化。在内体中检测到了与膜结合的形式,但在溶酶体中较少。生物合成研究结合相同的提取程序表明,巨噬细胞组织蛋白酶D最初作为一种无活性的与膜结合的前体被合成。该前体被加工成一种有活性的、与膜结合的形式,然后再加工成在溶酶体中发现的有活性的可溶性形式。我们的研究提供了证据表明:1)组织蛋白酶D存在于巨噬细胞的内体中;2)组织蛋白酶D以与膜结合的形式被转运到内体;3)与膜结合的形式是在内体和溶酶体中发现的可溶性形式的生物合成前体。